Results 291 to 300 of about 103,862 (301)

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Cancer Cell, 2018
Ewa Gogola, Wouter W Wiegant, Daniel J Vis   +2 more
exaly  

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency

Cancer Cell, 2018
Chaoyang Sun, Jun Yin, Jian Chen
exaly  

Sleep tight thanks to Parp1

Nature Reviews Molecular Cell Biology, 2021
exaly  

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

Cancer Cell, 2019
Daniel J Mcgrail, Chaoyang Sun, Marilyne Labrie   +2 more
exaly  

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer

Cancer Cell, 2016
Marina A Bellani, Ying Zou, Zeba N Singh
exaly  

DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity

Cell, 2018
Rajat Gupta, Kumar Somyajit, Takeo Narita   +2 more
exaly  

Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?

Nature Reviews Clinical Oncology, 2018
Alan Ashworth, Christopher J Lord
exaly  

Making the best of PARP inhibitors in ovarian cancer

Nature Reviews Clinical Oncology, 2010
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
exaly